Press Release


Biolidics' Laboratory Partner in China to Offer Laboratory-Developed Cancer Tests Using Biolidics' ClearCell FX1 System and CTChip FR1 Biochips
Apr 01, 2019 16:00 JST
Biolidics Limited ("Biolidics" or the "Company"), a medical technology company with a focus on cancer diagnostic solutions, is pleased to announce that its laboratory partner in China, Hunan Agen Medicine Laboratory Technology Co., Ltd. ("Hunan Agen Lab"), will start offering the LDTs (related to circulating tumour cells ("CTCs")) as clinical services to cancer patients, using Biolidics' ClearCell(R) FX1 System and CTChip(R) FR1 biochips.
More info..

Latest Release


More Latest Release >>